CAS 97919-22-7
:4-Amino-N-(5-cloro-2-quinoxalinil)bencenosulfonamida
- 4-Amino-N-(5-chloro-2-quinoxalinyl)benzenesulfonamide
- Chlorsulfaquinoxaline
- NSC 339004
- benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-
- CQS
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
Chloroquinoxaline sulfonamide
CAS:Chloroquinoxaline sulfonamideFórmula:C14H11ClN4O2SPureza:99.5%Peso molecular:334.784-Amino-N-(5-Chloroquinoxalin-2-Yl)Benzenesulfonamide
CAS:Fórmula:C14H11ClN4O2SPureza:95%Forma y color:SolidPeso molecular:334.7807Chlorsulfaquinoxaline
CAS:Applications Chlorsulfaquinoxaline is used to prepare carbonic anhydrase inhibitors 1,3,4-thiadiazole-2-sulfonamide derivatives as antitumor agents.
References Supuran, C., et al.: Eur. J. Med. Chem., 35, 867 (2000)Fórmula:C14H11ClN4O2SForma y color:NeatPeso molecular:334.78Chlorsulfaquinoxaline
CAS:Chlorsulfaquinoxaline is a chiral sulfonamide that inhibits the activity of cyclooxygenase-2 (COX-2) and 5-lipoxygenase. It has been shown to inhibit tumor growth in animal models of metastatic colorectal cancer as well as bowel disease. In addition, Chlorsulfaquinoxaline has been shown to have clinical relevance for inflammatory bowel disease and primary sclerosing cholangitis.
Chlorsulfaquinoxaline is an inhibitor of the COX-2 and 5-lipoxygenase enzymes, which are key enzymes in prostaglandin synthesis. It has been shown to inhibit tumor growth in animal models of metastatic colorectal cancer as well as bowel disease. In addition, Chlorsulfaquinoxaline has been shown to have clinical relevance for inflammatory bowel disease and primary sclerosing cholangitis.Fórmula:C14H11ClN4O2SPureza:Min. 95%Peso molecular:334.8 g/molChloroquinoxaline sulfonamide
CAS:Chloroquinoxaline sulfonamide (Chloroquinoxaline) is an organic micropollutant with antimicrobial activity.Fórmula:C14H11ClN4O2SPureza:99.79% - 99.89%Forma y color:SolidPeso molecular:334.781





